Evidence map›Paper›PMID 38113416›Full record

ArticleBioinformatics (Oxford, England)2023

Scaling up single-cell RNA-seq data analysis with CellBridge workflow.

Nima Nouri, Andre H Kurlovs, Giorgio Gaglia, Emanuele de Rinaldis, Virginia Savova

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nima NouriPrecision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.ORCID 0000-0001-8348-5717
Andre H KurlovsPrecision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.
Giorgio GagliaPrecision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.
Emanuele de RinaldisPrecision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.
Virginia SavovaPrecision Medicine and Computational Biology, Sanofi, Cambridge, MA 02141, United States.ORCID 0000-0002-5387-4161

Funding

Sanofi US
6 · The paper itself

Abstract

summarySingle-cell RNA sequencing (scRNA-seq) has revolutionized the study of gene expression at the individual cell level, unraveling unprecedented insights into cellular heterogeneity. However, the analysis of scRNA-seq data remains a challenging and time-consuming task, often demanding advanced computational expertise, rendering it impractical for high-volume environments and applications. We present CellBridge, an automated workflow designed to simplify the standard procedures entailed in scRNA-seq data analysis, eliminating the need for specialized computational expertise. CellBridge utilizes state-of-the-art computational methods, integrating a range of advanced functionalities, covering the entire process from raw unaligned sequencing reads to cell type annotation. Hence, CellBridge accelerates the pace of discovery by seamlessly enabling insights into vast volumes of scRNA-seq data, without compromising workflow control and reproducibility. AVAILABILITY AND IMPLEMENTATION: The source code, detailed documentation, and materials required to reproduce the results are available on GitHub and archived in Zenodo. For the CellBridge pre-processing step (v1.0.0), access the GitHub repository at https://github.com/Sanofi-Public/PMCB-ToBridge and the Zenodo archive at https://zenodo.org/records/10246161. For the CellBridge processing step (v1.0.0), visit the GitHub repository at https://github.com/Sanofi-Public/PMCB-CellBridge and the Zenodo archive at https://zenodo.org/records/10246046.

Indexed as

Gene Expression ProfilingSingle-Cell Gene Expression AnalysisReproducibility of ResultsSequence Analysis, RNASingle-Cell AnalysisSoftwareWorkflow

Identifiers

PMID38113416
PMCPMC10751228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.